Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression
- PMID: 15323594
- DOI: 10.4088/jcp.v65n0810
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression
Abstract
Objective: In the present study, we assessed the relationship between serum folate, vitamin B12, and homocysteine levels and clinical response in patients with major depressive disorder (MDD) who had previously failed to respond to open treatment with fluoxetine 20 mg/day and were enrolled in a 4-week, double-blind trial of either (1) fluoxetine dose increase, (2) lithium augmentation of fluoxetine, or (3) desipramine augmentation of fluoxetine.
Method: Fifty-five outpatients (mean +/- SD age = 41.7 +/- 10.6 years; 50.9% women) with MDD as assessed with the Structured Clinical Interview for DSM-III-R who were enrolled in the double-blind trial had serum folate, vitamin B12, and homocysteine measurements completed at baseline (prior to fluoxetine treatment initiation). Folate levels were classified as either low (< or = 2.5 ng/mL) or normal. Vitamin B12 levels were classified as either low (< or = 200 pg/mL) or normal. Homocysteine levels were classified as either elevated (> or = 13.2 micromol/L) or normal. With the use of a logistic regression, we then assessed the relationship between (1) low or normal folate levels, (2) normal or low B12 levels, and (3) elevated or normal homocysteine levels and clinical response to double-blind treatment. The study was conducted from November 1992 to January 1999.
Results: Low serum folate levels (chi2=3.626, p =.04), but not elevated homocysteine (p >.05) or low vitamin B12 levels (p >.05), were associated with poorer response to treatment. The response rates for patients with (N = 14) and without (N = 38) low folate levels were 7.1% versus 44.7%, respectively.
Conclusion: Low serum folate levels were found to be associated with further treatment resistance among patients with fluoxetine-resistant MDD.
Similar articles
-
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy.J Clin Psychiatry. 2004 Aug;65(8):1096-8. doi: 10.4088/jcp.v65n0811. J Clin Psychiatry. 2004. PMID: 15323595 Clinical Trial.
-
Folate, vitamin B12, and homocysteine in major depressive disorder.Am J Psychiatry. 1997 Mar;154(3):426-8. doi: 10.1176/ajp.154.3.426. Am J Psychiatry. 1997. PMID: 9054796 Clinical Trial.
-
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.Int J Neuropsychopharmacol. 2005 Dec;8(4):523-8. doi: 10.1017/S1461145705005195. Epub 2005 May 9. Int J Neuropsychopharmacol. 2005. PMID: 15877935 Clinical Trial.
-
Treatment of depression: time to consider folic acid and vitamin B12.J Psychopharmacol. 2005 Jan;19(1):59-65. doi: 10.1177/0269881105048899. J Psychopharmacol. 2005. PMID: 15671130 Review.
-
Folic acid with or without vitamin B12 for cognition and dementia.Cochrane Database Syst Rev. 2003;(4):CD004514. doi: 10.1002/14651858.CD004514. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004514. doi: 10.1002/14651858.CD004514.pub2 PMID: 14584018 Updated. Review.
Cited by
-
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Neuroscience. 2013 Aug 29;246:199-229. doi: 10.1016/j.neuroscience.2013.04.060. Epub 2013 May 3. Neuroscience. 2013. PMID: 23644052 Free PMC article. Review.
-
Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.CNS Spectr. 2012 Jun;17(2):76-86. doi: 10.1017/S1092852912000430. CNS Spectr. 2012. PMID: 22789065 Free PMC article.
-
Therapeutic options for treatment-resistant depression.CNS Drugs. 2010 Feb;24(2):131-61. doi: 10.2165/11530280-000000000-00000. CNS Drugs. 2010. PMID: 20088620 Review.
-
Vitamin B12 supplementation in treating major depressive disorder: a randomized controlled trial.Open Neurol J. 2013 Nov 15;7:44-8. doi: 10.2174/1874205X01307010044. eCollection 2013. Open Neurol J. 2013. PMID: 24339839 Free PMC article.
-
Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase.J Neurosci. 2008 Jul 9;28(28):7219-30. doi: 10.1523/JNEUROSCI.0940-08.2008. J Neurosci. 2008. PMID: 18614692 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical